The Relationship between Epicardial Fat Thickness and Endothelial Dysfunction in Type I Diabetes Mellitus
Corresponding Author
Abdullah Nabi Aslan M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Address for correspondence and reprint requests: Abdullah Nabi Aslan, M.D., Department of Cardiology, Ankara Ataturk Education and Research Hospital, Bilkent 06800, Ankara, Turkey. Fax: +90-3122912745;
E-mail: [email protected]
Search for more papers by this authorTelat Keleş M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorHüseyin Ayhan M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorHacı Ahmet Kasapkara M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorMurat Akçay M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorTahir Durmaz M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorCenk Sarı M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorSerdal Baştuğ M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorBekir Çakır M.D.
Department of Endocrinology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorEngin Bozkurt M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorCorresponding Author
Abdullah Nabi Aslan M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Address for correspondence and reprint requests: Abdullah Nabi Aslan, M.D., Department of Cardiology, Ankara Ataturk Education and Research Hospital, Bilkent 06800, Ankara, Turkey. Fax: +90-3122912745;
E-mail: [email protected]
Search for more papers by this authorTelat Keleş M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorHüseyin Ayhan M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorHacı Ahmet Kasapkara M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorMurat Akçay M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorTahir Durmaz M.D.
Department of Cardiology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorCenk Sarı M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorSerdal Baştuğ M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorBekir Çakır M.D.
Department of Endocrinology, Faculty of Medicine, Yıldırım Beyazıt University, Ankara, Turkey
Search for more papers by this authorEngin Bozkurt M.D.
Department of Cardiology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey
Search for more papers by this authorAbstract
Background and Aim
Epicardial adipose tissue (EAT) is a new independent marker of coronary artery disease (CAD). The aim of this study was to investigate the relationship between epicardial fat thickness (EFT) and endothelial dysfunction (ED) in patients with type I diabetes mellitus (TIDM).
Methods and Results
Seventy-six type I diabetic patients (diabetes duration 11.7 ± 8,1 years, aged 30.6 ± 10 years; female/male: 38/38) and 36 healthy controls were enrolled into the study. Fasting plasma glucose (FPG), lipid panel, glycosylated hemoglobin (HbA1C), high-sensitive C-reactive protein (hsCRP), and fibrinogen levels were determined. EFT was measured via two-dimensional (2D) M-mode echocardiography. Endothelial function was assessed as flow-mediated dilatation (FMD) at the brachial artery using high-resolution ultrasound. EFT was significantly higher in patients compared to controls (3.56 ± 0.48 mm vs. 3.03 ± 0.48 mm, P < 0.001). In addition, significant differences were observed between the patient and control groups in terms of FMD (6.70% ± 1.63 vs. 9.99% ± 1.84, respectively, P < 0.001). EFT was shown to be correlated negatively with FMD (r: −0.94, P < 0.001) and positively with hsCRP (r: 0.41, P < 0.001) and fibrinogen (r: 0. 31, P = 0.007). Multiple regression analysis showed EFT to be an independent factor influencing the endothelial function.
Conclusion
There was inverse relationship between EFT and endothelial function in this study. EFT measured easily by transthoracic echocardiography may be a useful parameter in the assessment of patients with TIDM.
References
- 1The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
- 2U.K. Prospective Diabetes Study Group: UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group. Diabetes Care 1998; 21: 87–92.
- 3 Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of the long term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999; 22: 99–111.
- 4Krolewski AS, Kosinski EJ, Warram JH, et al: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59: 750–755.
- 5Morrish NJ, Stevens LK, Fuller JH, et al: Incidence of disease macrovascular complications in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 1991; 34: 584–589.
- 6Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035–2038.
- 7Schram MT, Chaturvedi N, Schalkwijk C, et al: Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the Prospective EURODIAB Complications Study. Diabetes Care 2003; 26: 2165–2173.
- 8Stehouwer CD, Gall MA, Twisk JW, et al: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with the risk of death. Diabetes 2002; 51: 1157–1165.
- 9Sacks HS, Fain JN: Human epicardial adipose tissue: a review. Am Heart J 2007; 153: 907–917.
- 10Iacobellis G, Sharma AM: Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des 2007; 13: 2180–2184.
- 11De Vos AM, Prokop M, Roos CJ, et al: Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J 2008; 29: 777–783.
- 12Jarvisalo MJ, Raitakari M, Toikka JO, et al: Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004 Apr 13; 109: 1750–1755.
- 13Juonala M, Viikari JS, Laitinen T, et al: Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 2004; 110: 2918–2923.
- 14Kraiczi H, Caidahl K, Samuelsson A, et al: Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001; 119: 1085–1091.
- 15Kato M, Roberts-Thomson P, Philips BG, et al: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607–2610.
- 16Corretti MC, Anderson TJ, Benjamin EJ, et al: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257–265.
- 17Yan RT, Anderson TJ, Charbonneau F, et al: Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005; 45: 1980–1986.
- 18Joannides R, Haefeli WE, Linder L, et al: Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314–1319.
- 19Wall RT, Rubenstein MD, Cooper SL: Studies on the cellular basis of atherosclerosis: the effects of atherosclerosis risk factors on platelets and the vascular endothelium. Diabetes 1981; 30: 39–43.
- 20Celermajer DS, Sorensen KE, Bull C, et al: Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Cardiol 1994; 24: 1468–1474.
- 21Hashimoto M, Eto M, Akishita M, et al: Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 1999; 19: 2795–2800.
- 22Vogel RA: Measurement of endothelial function by brachial artery flow- mediated vasodilation. Am J Cardiol 2001; 88: 31E–34E.
- 23Singh TP, Groehn H, Kazmers A: Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 2003; 41: 661–665.
- 24Clarkson P, Celermajer DS, Donald AE, et al: Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996; 28: 573–579.
- 25Ho E, Shimada Y: Formation of the epicardium studied with the scanning electron microscope. Dev Biol 1978; 66: 579–585.
- 26Iacobellis G, Ribaudo MC, Assael F, et al: Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003; 88: 5163–5168.
- 27Yazıcı D, Özben B, Yavuz D, et al: Epicardial adipose tissue thickness in type 1 diabetic patients. Endocrine 2011; 40: 250–255.
- 28Iacobellis G, Assael F, Ribaudo MC, et al: Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304–310.
- 29Iacobellis G, Barbaro G, Gerstein HC: Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol 2008; 128: 424–426.
- 30Iacobellis G, Pellicelli AM, Sharma AM, et al: Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol 2007; 99: 1470–1472.
- 31Lacobellis G, Barbaro G: The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 2008; 40: 442–445.
- 32Panagiotakos DB, Pitsavos C, Yannakoulia M, et al: The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 2005; 183: 308–315.
- 33Mazurek T, Zhang L, Zalewski A, et al: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460–2466.
- 34Prati F, Arbustini E, Labellarte A, et al: Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions. Eur Heart J 2003; 24: 329–336.
- 35Ishii T, Asuwa N, Masuda S, et al: The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol 1998; 185: 4–9.
10.1002/(SICI)1096-9896(199805)185:1<4::AID-PATH50>3.0.CO;2-3 CAS PubMed Web of Science® Google Scholar
- 36Chaowalit N, Somers VK, Pellikka PA, et al: Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 2006; 186: 354–359.
- 37Verhagen SN, Visseren FL: Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011; 214: 3–10.
- 38De Feyter PJ: Epicardial adipose tissue: an emerging role for the development of coronary atherosclerosis. Clin Cardiol 2011; 34: 143–144.
- 39Bachar GN, Dicker D, Kornowski R, et al: Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol 2012; 110: 534–538.
- 40Kim BJ, Kim BS, Kang JH: Echocardiographic epicardial fat thickness is associated with arterial stiffness. Int J Cardiol 2013; 167: 2234–2238.
- 41Mahfouz RA, Alzaiat A, Yousry A. Relationship of epicardial fat thickness with endothelial and cardiac functions in children with family history of type 2 diabetes mellitus. Echocardiography 2015; 32: 28–33.
- 42Rajala MW, Qi Y, Patel HR, et al: Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004; 53: 1671–1679.
- 43Balta S, Demirkol S, Arslan Z, et al: Epicardial fat thickness should be evaluated with other inflammatory markers and cardiovascular risk factors. Echocardiography 2013; 30: 739.
Citing Literature
